サポート>ブログ>組換え抗体(Recombinant Antibodies)

組換え抗体(Recombinant Antibodies)

Biointron 2024-01-20
Recombinant-antibody.jpg
Image credit: DOI: 10.3389/fvets.2018.00175

Recombinant antibodies are synthetic proteins created by combining different parts of antibody molecules from different sources. These molecules can be customized to target specific antigens, making them a powerful tool in the fields of medicine and biotechnology. 

Traditional antibodies are made by the body's immune system to identify and neutralize foreign substances like bacteria or viruses. Recombinant antibodies, on the other hand, are designed in a laboratory to target specific molecules, such as those found on the surface of cancer cells. 

One of the main advantages of recombinant antibodies is their ability to be produced on a large scale, making them useful in the development of diagnostic tools and therapeutic drugs. At Biointron, we specialize in creating high-quality recombinant antibodies through our fast and efficient platform. 

Our team of experts can create recombinant antibodies from scratch, starting with gene synthesis all the way to protein purification. Our service is designed to accelerate your research and drug discovery projects with high-quality recombinant antibodies at an economical price. 

To learn more about how our recombinant antibody service can benefit your research, visit our website at https://www.biointron.com/recombinant-antibody-production.html. 

Subscribe to our ブログ
Recommended Articles
人間の免疫システムの活用:自然な防御から精密医療へ

免疫・PAMP/DAMP・革新的抗体療法の解説

Aug 08, 2025
抗体薬物複合体(ADC)の基礎レビュー:作用機序、臨床進展、設計最適化、課題、および将来

抗体薬物複合体(Antibody-Drug Conjugates, ADC)は、がん治療において革新的なターゲット型治療薬の一つであり、モノクローナル抗体(mA……

Aug 05, 2025
抗体機能におけるFc糖鎖の役割

抗体の機能は、Fc領域の糖鎖修飾状態に大きく依存しています。

Jun 25, 2025
AIS 2025 – フランス:ハイライトとイベント総括

第13回抗体産業シンポジウム(Antibody Industrial Symposium 2025)が、2025年6月25日から26日にかけてフランス・トゥール……

Jun 22, 2025

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。